Results 21 to 30 of about 1,915,304 (214)
Linear Micro-patterned Drug Eluting Balloon (LMDEB) for Enhanced Endovascular Drug Delivery. [PDF]
In-stent restenosis (ISR) often occurs after applying drug eluting stents to the blood vessels suffering from atherosclerosis or thrombosis. For treatment of ISR, drug eluting balloons (DEB) have been developed to deliver anti-proliferative drugs to the ...
Lee K +12 more
europepmc +2 more sources
Introduction Several treatment modalities have been proposed and used for bare-metal in-stent restenosis (ISR). We compared the efficacy of drug-eluting balloons (DEB) versus drug-eluting stents (DES) in the treatment of ISR in terms of binary restenosis,
Neeraj Mahajan +2 more
doaj +2 more sources
Drug-eluting coronary stents – focus on improved patient outcomes
Zehra Jaffery, Amit Prasad, John H Lee, Christopher J WhiteDepartment of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: The development of stent has been a major advance in
Jaffery Z, Prasad A, Lee JH, White CJ
doaj +1 more source
Network meta-analysis of balloon angioplasty, nondrug metal stent, drug-eluting balloon, and drug-eluting stent for treatment of infrapopliteal artery occlusive disease [PDF]
PURPOSE:We aimed to conduct a network meta-analysis of mixed treatments for the infrapopliteal artery occlusive disease.METHODS:We searched randomized controlled trials (RCTs) regarding balloon angioplasty (BA), nondrug metal stent (NDMS), drug-eluting ...
Yaowen Xiao +3 more
doaj +2 more sources
Objective: To investigate the safety and efficacy of a percutaneous revascularization strategy that is based on the use of drug-coated balloon for the treatment of patients with acute coronary syndrome and de novo Medina type 0,1,0 or 0,0,1 left main ...
Emrah Erdoğan +13 more
doaj +1 more source
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. [PDF]
BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death.
Kirtane, Ajay J +14 more
core +1 more source
OBJECTIVE Owing to the lack of comparative evidence between the endovascular technologies for arteriovenous fistula (AVF) stenosis treatments, we sought to summarize the reported data comparing the effectiveness of different endovascular approaches for ...
Vanessa Rokoszak +8 more
semanticscholar +1 more source
Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is still not well defined. Various treatment modalities include plain old balloon angioplasty (POBA), metallic stent, cutting or scoring balloon and drug ...
Surender Deora +3 more
doaj +1 more source
QUESTION: What is the evidence available on the use of drug-coated balloons (DCB) in the de novo lesion setting? ANSWER: The use of DCB to treat de novo lesions is the most compelling argument regarding this technology, an area that has advanced ...
Bernardo Cortese
doaj +1 more source
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]
BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)
Brodie, Bruce R. +23 more
core +1 more source

